Number of Trials
The following table compares the number of open trials
sorted by trial phase in the 12-month reporting period
at NCI-designated Cancer Centers.
Figure 14. Number of Trials By Phase
| Number of Open Trials* |
| Phase |
Total |
Median |
| 0 |
2 |
0 |
| I |
2,526 |
40 |
| I/II |
1,139 |
14 |
| II |
5,663 |
88 |
| II/III |
118 |
1 |
| III |
5,093 |
85 |
| III/IV |
8 |
0 |
| IV |
92 |
1 |
| IV/V |
1 |
0 |
| V |
2 |
0 |
| Pilot |
1,286 |
17 |
| N/A |
8,024 |
95 |
| TOTAL TRIALS* --- 23,954 |
*It is important to note that these are not
necessarily unique trials; the same trial may be open at multiple centers.
| |
|
|
Number of Patients
The following table compares the number of patients accrued
to open trials by phase in the 12-month reporting period
at NCI-designated Cancer Centers.
Figure 15. Patient Accrual By Phase
| Number of Patients Accrued |
| Phase |
Total |
Median |
| 0 |
21 |
0 |
| I |
14,321 |
97 |
| I/II |
4,040 |
38 |
| II |
20,540 |
204 |
| II/III |
399 |
1 |
| III |
17,652 |
209 |
| III/IV |
48 |
0 |
| IV |
576 |
1 |
| IV/V |
3 |
0 |
| V |
2 |
0 |
| Pilot |
14,010 |
90 |
| N/A |
346,873 |
3,193 |
| TOTAL PATIENTS --- 418,485 |
Descriptions of the phases used above can be found on page 13 in the summary instructions.
Epidemiologic, cancer control/behavioral, observational, ancillary, correlative or other biological studies are
identified as "N/A."
|
